Literature DB >> 14581387

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Mark J Sarnak, Andrew S Levey, Anton C Schoolwerth, Josef Coresh, Bruce Culleton, L Lee Hamm, Peter A McCullough, Bertram L Kasiske, Ellie Kelepouris, Michael J Klag, Patrick Parfrey, Marc Pfeffer, Leopoldo Raij, David J Spinosa, Peter W Wilson.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14581387     DOI： 10.1161/01.CIR.0000095676.90936.80

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  950 in total

1.  Efficacy and safety of more potent antiplatelet therapy with vorapaxar in patients with impaired renal function.

Authors:  Simon Correa; Marc P Bonaca; Benjamin M Scirica; Sabina A Murphy; Erica L Goodrich; David A Morrow; Michelle L O'Donoghue
Journal:  J Thromb Thrombolysis       Date:  2019-04       Impact factor: 2.300

2.  Radiation dose associated with renal failure mortality: a potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation.

Authors:  Michael Jacob Adams; Eric J Grant; Kazunori Kodama; Yukiko Shimizu; Fumiyoshi Kasagi; Akihiko Suyama; Ritsu Sakata; Masazumi Akahoshi
Journal:  Radiat Res       Date:  2011-12-07       Impact factor: 2.841

3.  Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal disease.

Authors:  Thomas D Nolin; Rosemary Ouseph; Jonathan Himmelfarb; M Elizabeth McMenamin; Richard A Ward
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

4.  Chronic kidney disease in octogenarians.

Authors:  Shani Shastri; Hocine Tighiouart; Ronit Katz; Dena E Rifkin; Linda F Fried; Michael G Shlipak; Anne B Newman; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

5.  A call to action: variability in guidelines for cardiac evaluation before renal transplantation.

Authors:  Scott E Friedman; Robert T Palac; David M Zlotnick; Michael C Chobanian; Salvatore P Costa
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

6.  Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Authors:  Pupalan Iyngkaran; Merlin Thomas; William Majoni; Nagesh S Anavekar; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2012-10-31       Impact factor: 2.041

Review 7.  Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

Authors:  Ankur Jindal; Mariana Garcia-Touza; Nidhi Jindal; Adam Whaley-Connell; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-08-01       Impact factor: 4.741

8.  Connecting the C's: coronaries, creatinine, compliance, CRUSADE.

Authors:  Alan K Berger; Charles A Herzog
Journal:  Am J Kidney Dis       Date:  2009-03       Impact factor: 8.860

Review 9.  Managing dyslipidemia in chronic kidney disease.

Authors:  Daniel E Weiner; Mark J Sarnak
Journal:  J Gen Intern Med       Date:  2004-10       Impact factor: 5.128

Review 10.  Vitamin D and Calcimimetics in Cardiovascular Disease.

Authors:  Kenneth Lim; Takayuki Hamano; Ravi Thadhani
Journal:  Semin Nephrol       Date:  2018-05       Impact factor: 5.299
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.